300871.SZ SHZ
Hvsen Biotechnology Co., Ltd.
1W: -2.8%
1M: -6.4%
3M: -9.7%
YTD: -22.1%
1Y: -7.9%
3Y: +27.2%
5Y: -48.0%
¥21.10 ($3.15)
+0.48 (+2.33%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$44M
-53.2% ▼
5Y CAGR: -16.2%
Capital Expenditures
$194M
-5.5% ▼
5Y CAGR: +9.6%
Free Cash Flow
-$151M
-65.1% ▼
Dividends Paid
$59M
-20.8% ▼
Buybacks
$3M
+1.6% ▲
Net Change in Cash
-$45M
+8.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $150M | $133M | $53M | $17M | -$20M |
| Depreciation & Amort. | $19M | $29M | $63M | $120M | $113M |
| Stock-Based Comp. | $0 | $764K | -$764K | $0 | $0 |
| Change in Working Capital | -$130M | -$19M | -$31M | -$76M | -$114M |
| Other Non-Cash Items | $9M | $13M | $13M | $32M | $64M |
| Operating Cash Flow | $48M | $156M | $97M | $93M | $44M |
| — Investing Activities — | |||||
| Capital Expenditures | -$231M | -$600M | -$429M | -$184M | -$194M |
| Acquisitions (Net) | $231M | $600M | $74K | $0 | $0 |
| Investment Purchases | -$500M | -$210M | -$1.0B | -$986M | -$576M |
| Investment Sales | $60M | $625M | $699M | $1.1B | $668M |
| Other Investing | -$231M | -$600M | $1 | $14M | $423K |
| Investing Cash Flow | -$670M | -$185M | -$750M | -$100M | -$102M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$6M | $62M | $68M | -$33M | $444K |
| Stock Repurchased | $0 | $0 | -$54M | -$3M | -$3M |
| Dividends Paid | -$6M | -$45M | -$55M | -$49M | -$59M |
| Other Financing | $838M | $696M | -$48M | $44M | $76M |
| Financing Cash Flow | $826M | $710M | -$35M | -$41M | $14M |
| Net Change in Cash | $204M | $681M | -$688M | -$49M | -$45M |
| Cash End of Period | $286M | $966M | $279M | $230M | $185M |
| Free Cash Flow | -$182M | -$444M | -$332M | -$91M | -$151M |